AMRX - Amneal Pharmaceuticals Q2 2023 Earnings Preview

2023-08-03 14:20:38 ET

• Amneal Pharmaceuticals ( NYSE: AMRX ) is scheduled to announce Q2 earnings results on Friday, August 4th, before market open.
• The consensus EPS Estimate is $0.10 (-47.4% Y/Y) and the consensus Revenue Estimate is $565.11M (+1.1% Y/Y).
• Over the last 2 years, AMRX has beaten EPS estimates 50% of the time and has beaten revenue estimates 63% of the time.
• Over the last 3 months, EPS estimates have seen 1 upward revision and 4 downward. Revenue estimates have seen 0 upward revisions and 4 downward.

For further details see: